LOGO
LOGO

Quick Facts

WuXi PharmaTech Q4 Profit Rises

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

WuXi PharmaTech (Cayman) Inc. (WX), Thursday reported fourth-quarter net income of $23.8 million or $0.33 per American Depositary Share, slightly up from $23.5 million or $0.31 per ADS last year.

Adjusted earnings for the quarter was $0.38 per ADS compared to $0.36 per ADS last year.

Net revenues for the quarter grew 15.8 percent to $125.7 million from $108.5 million for the quarter.

Analysts polled by Thomson Reuters estimated earnings of $0.30 per share on revenues of $123.7 million for the quarter.

Looking forward to the first quarter, the company expects earnings of $0.26 to $0.27 per ADS, adjusted earnings of $0.31 to $0.32 per ADS and revenues of $129 million to $131 million.

Analyst estimate earnings of $0.31 per share on revenues of $131.8 million for the quarter.

For the full year 2013, the company expects earnings of $1.26 to $1.30 per ADS, adjusted earnings of $1.49 to $1.53 per ADS, and revenues of $565 million to $575 million.

Analysts currently estimate earnings of $1.44 per share on revenues of $571.58 million for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19